Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-445-8110
Fax+1 216-445-6259
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1980 - 1987
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
Certifications & Licensure
OH State Medical License 1994 - 2027
PA State Medical License 1982 - 1994
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- AVONEX® Combination Trial - "ACT" Start of enrollment: 2003 Jun 01
- Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS Start of enrollment: 2011 Mar 01
- Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Publications & Presentations
PubMed
- Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literature.Daniele Mandia, Natalia Shor, Alise K Carlson, Emmanuel Obusez, Jeffrey A Cohen
Multiple Sclerosis and Related Disorders. 2025-07-01 - Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials.Sarah Harris, Giancarlo Comi, Bruce A C Cree, Douglas L Arnold, Lawrence Steinman
European Journal of Neurology. 2025-06-01 - Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein-IgG Associated Disease Compared to Multiple Sclerosis.Eileen Galvani, Jeffrey A Cohen, John T Martin, Kunio Nakamura, Amy Kunchok
Brain and Behavior. 2025-03-01
Press Mentions
- Long-Term Ocrelizumab Shows Benefit in Progressive MSNovember 3rd, 2020
- Long-Term Ocrelizumab Benefits Seen in PPMSNovember 2nd, 2020
Pregnant Women with MS Show Increased NfLSeptember 28th, 2020- Join now to see all
Professional Memberships
- Member
External Links
- Cleveland Clinichttp://my.clevelandclinic.org/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
